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The answer to the letter from Demirkol et al. [1], 
in reference to the article “Vitamin D level and 
extent of coronary stenotic lesions in patients with 
first acute myocardial infarction”.
Our study involved patients admitted to our 
hospital due to the first acute ST-segment elevation 
myocardial infarction treated with primary percuta-
neous coronary intervention. Myocardial infarction 
was the first symptom of coronary artery disease. 
Patients with factors that affect the level of vitamin D 
such as a history of malignancy within the past 
5 years, abnormal liver or renal function (serum 
aminotransferase activity > 40 IU/L, GFR < 60 mL/ 
/min/1.72 m2), thyroid or parathyroid disease, 
sarcoidosis, tuberculosis, rickets type I, II, III, 
hypophosphatemic rickets, nephrotic syndrome, 
autoimmune disease, peripheral arterial disease 
and alcohol consumption were excluded from the 
study [2–6]. However, the level of vitamin D can be 
affected by many conditions, then further studies 
will evaluate all of these conditions that can affect 
vitamin D levels in patients with acute myocardial 
infarction.
In our study, the angiographic severity of 
coronary artery disease was determined based on 
the Gensini score [7]. Independently, the study 
population was divided into patients with single 
and multivessel coronary artery disease. There is 
no doubt that future studies are needed to obtain 
a better clarification of the physiologic range of 
vitamin D for preventing atherosclerosis and car-
diovascular disease.
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